Cook PET/CT in Prostate Cancer

1. Auflage 2017
ISBN: 978-3-319-57624-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 60 Seiten, eBook

Reihe: Clinicians’ Guides to Radionuclide Hybrid Imaging

This pocket book explains the significant and well-documented impact that PET/CT can have on the management of prostate cancer through the provision of high-quality evidence regarding function and structure. Up-to-date information is supplied on the relevance of PET/CT to diagnosis, treatment planning, and therapy, including the emerging role of PET/CT with PSMA. Readers will also find clear explanation of the relation of the clinical and pathological background to imaging and the value of PET/CT compared with conventional radiological imaging. The book will be an excellent asset for referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. It is published within the Springer series
Clinicians’ Guides to Radionuclide Hybrid Imaging
, which presents contributions from professionals worldwide who share a common purpose in promoting nuclear medicine asan important imaging specialty for the diagnosis and management of oncological and non-oncological conditions.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Cook, Gary

Inhaltsverzeichnis

Epidemiology and Clinical Features of Prostate cancer.- Pathology of prostate cancer.- Management of Prostate Cancer.- Prostate cancer: Radiological Imaging.- The Role of PET/CT in Prostate Cancer Management.- Role of radiolabelled small molecules binding to PSMA in diagnosis and therapy of prostate cancer.- PET/CT in radiotherapy planning: current evidence in prostate cancer.

Über Autor(innen)

Gary Cook
is Professor of PET Imaging in the King’s College London and Guy’s & St Thomas’ PET Centre, the head of the Cancer Imaging Department in the Division of Imaging Sciences and Biomedical Engineering, King’s College London, and an honorary consultant at Guy’s & St Thomas’ Hospitals, London, UK. He is a member of the Guy’s and St Thomas’ Hospitals prostate cancer multidisciplinary team, imaging lead for the King’s Health Partners Prostate Cancer Research group, and a member of the UK National Cancer Research Institute Prostate Cancer Clinical Studies Group.